LENALIDOMIDE

Product NDC
60219-1717
11-digit product format
602191717
Labeler code
60219
Product ID
60219-1717_85e664d1-1d56-4b9b-b2a1-96b32b5b1a7e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
lenalidomide
Dosage form
CAPSULE
Route
ORAL
Labeler
Amneal Pharmaceuticals NY LLC
Application
ANDA216213
Marketing category
ANDA
Marketing start
2025-02-12
Substance
LENALIDOMIDE
Active strength
15 mg/1
Pharmacologic classes
Thalidomide Analog [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

openFDA Listing Details

Product ID
60219-1717_85e664d1-1d56-4b9b-b2a1-96b32b5b1a7e
SPL ID
85e664d1-1d56-4b9b-b2a1-96b32b5b1a7e
Product type
HUMAN PRESCRIPTION DRUG
Finished product
Yes
Brand name base
LENALIDOMIDE
Generic name
lenalidomide
Dosage form
CAPSULE
Route
ORAL
Marketing start
2025-02-12
Marketing category
ANDA
Application number
ANDA216213
Pharmacologic classes
Thalidomide Analog [EPC]
Listing expiration
2027-12-31

openFDA Active Ingredients

IngredientStrength
LENALIDOMIDE15 mg/1

openFDA Harmonized Identifiers

FieldValues
UniiF0P408N6V4
Rxcui602910, 602912, 643712, 643720, 1242231, 1428947
Spl Set Idda7b5dda-79ed-4c4a-88aa-52394fdc7c54
Manufacturer NameAmneal Pharmaceuticals NY LLC

openFDA Package Details

Package NDCDescriptionMarketing startSample
60219-1717-121 CAPSULE in 1 BOTTLE (60219-1717-1)2025-02-12No
60219-1717-2100 CAPSULE in 1 BOTTLE (60219-1717-2)2025-02-12No

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
F0P408N6V4LENALIDOMIDE191732-72-6LENALIDOMIDE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
60219-1717-16021917170121 CAPSULE in 1 BOTTLE (60219-1717-1) 21 capsule2025-02-12NoNoHistorical
60219-1717-260219171702100 CAPSULE in 1 BOTTLE (60219-1717-2) 100 capsule2025-02-12NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
LENALIDOMIDEAmneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited2026-05-14HUMAN PRESCRIPTION DRUG LABEL6